Coldstream Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$674K Sell
1,272
-87
-6% -$40.2K 0.01% 619
2026
Q1
$653K Sell
1,359
-40
-3% -$20.5K 0.01% 615
2025
Q4
$786K Sell
1,399
-33
-2% -$18.7K 0.01% 534
2025
Q3
$736K Sell
1,432
-8
-0.6% -$3.49K 0.01% 569
2025
Q2
$452K Sell
1,440
-113
-7% -$33.9K 0.01% 706
2025
Q1
$473K Buy
1,553
+69
+5% +$23.2K 0.01% 629
2024
Q4
$493K Sell
1,484
-274
-16% -$92.9K 0.01% 615
2024
Q3
$599K Buy
1,758
+436
+33% +$166K 0.01% 546
2024
Q2
$544K Buy
1,322
+32
+2% +$12.7K 0.01% 521
2024
Q1
$521K Buy
1,290
+336
+35% +$118K 0.01% 535
2023
Q4
$292K Buy
954
+45
+5% +$12.1K 0.01% 719
2023
Q3
$220K Buy
909
+2
+0.2% +$512 0.01% 722
2023
Q2
$218K Buy
+907
New +$188K 0.01% 759
2023
Q1
– Sell
-946
Closed -$201K – 851
2022
Q4
$201K Buy
+946
New +$189K 0.01% 767
2022
Q1
– Sell
-964
Closed -$209K – 827
2021
Q4
$209K Buy
+964
New +$202K 0.01% 790
2021
Q3
– Sell
-1,409
Closed -$249K – 491
2021
Q2
$249K Sell
1,409
-8
-0.6% -$1.38K 0.01% 442
2021
Q1
$233K Sell
1,417
-40
-3% -$6.12K 0.01% 387
2020
Q4
$203K Buy
+1,457
New +$184K 0.01% 395

Other funds holding MEDP

Coldstream Capital Management's MEDP Position: Q2 2026 in Review

Coldstream Capital Management reduced its Medpace (MEDP) stake by 6.4% in Q2 2026, selling an estimated $40.2K and leaving 1,272 shares worth $674K. The position accounts for 0.01% of the portfolio, ranked #619.

Coldstream Capital Management first reported a position in MEDP in Q4 2020 and has held it in 18 quarters since. The position peaked at $786K in Q4 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Coldstream Capital Management held 1,272 shares of Medpace worth $674K as of Q2 2026.
  • Coldstream Capital Management sold 87 Medpace shares in Q2 2026, an estimated $40.2K.
  • Medpace made up 0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #619 holding.
  • Coldstream Capital Management first reported a position in Medpace in Q4 2020 and has held it in 18 quarters since.
  • Coldstream Capital Management's Medpace position peaked at $786K in Q4 2025.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.